Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Blood
|
March 2, 2013
Saving orphans: BRAF targeting of histiocytosis
Mark L Heaney
European Journal of Haematology
|
March 18, 2015
Zeroing in on cereblon
Mark L Heaney
The Lancet. Haematology
|
December 31, 2021
Can the treatment of myeloproliferative neoplasms be both good and bad for you?
Mark L Heaney
Clinical Advances in Hematology & Oncology : H&O
|
October 31, 2014
Sequencing treatment in chronic myeloid leukemia: the first choice may be the hardest
Mark L Heaney
Current Hematologic Malignancy Reports
|
April 11, 2013
Acute myeloid leukemia following a myeloproliferative neoplasm: clinical characteristics, genetic features and effects of therapy
Mark L Heaney, Gabriela Soriano
Expert Review of Anticancer Therapy
|
February 17, 2021
Glasdegib in newly diagnosed acute myeloid leukemia
Shawn M Sarkaria, Mark L Heaney
Leukemia & Lymphoma
|
May 10, 2002
Cladribine underdosing in hairy-cell leukemia: a cause for apparent response failure
David W Golde, Andrzej Jakubowiak, Janine Caggiano, et al.
International Journal of Surgical Pathology
|
May 14, 2013
Acute myeloid leukemia with t(9;11) (p22;q23) and synchronous Langerhans cell histiocytosis
Olga L Bohn, Jarett L Feldman, Mark L Heaney, et al.
Archives of Dermatology
|
January 23, 2008
Multiple erythematous eroded patches and papules on the scalp
Sanjay Mandal, Steven Q Wang, Klaus Busam, et al.
Molecular and Cellular Biology
|
September 1, 2010
Inhibition of human peptide deformylase disrupts mitochondrial function
Sindy Escobar-Alvarez, Jeffrey Gardner, Aneesh Sheth, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Blood
|
March 2, 2013
Saving orphans: BRAF targeting of histiocytosis
Mark L Heaney
European Journal of Haematology
|
March 18, 2015
Zeroing in on cereblon
Mark L Heaney
The Lancet. Haematology
|
December 31, 2021
Can the treatment of myeloproliferative neoplasms be both good and bad for you?
Mark L Heaney
Clinical Advances in Hematology & Oncology : H&O
|
October 31, 2014
Sequencing treatment in chronic myeloid leukemia: the first choice may be the hardest
Mark L Heaney
Current Hematologic Malignancy Reports
|
April 11, 2013
Acute myeloid leukemia following a myeloproliferative neoplasm: clinical characteristics, genetic features and effects of therapy
Mark L Heaney, Gabriela Soriano
Expert Review of Anticancer Therapy
|
February 17, 2021
Glasdegib in newly diagnosed acute myeloid leukemia
Shawn M Sarkaria, Mark L Heaney
Leukemia & Lymphoma
|
May 10, 2002
Cladribine underdosing in hairy-cell leukemia: a cause for apparent response failure
David W Golde, Andrzej Jakubowiak, Janine Caggiano, et al.
International Journal of Surgical Pathology
|
May 14, 2013
Acute myeloid leukemia with t(9;11) (p22;q23) and synchronous Langerhans cell histiocytosis
Olga L Bohn, Jarett L Feldman, Mark L Heaney, et al.
Archives of Dermatology
|
January 23, 2008
Multiple erythematous eroded patches and papules on the scalp
Sanjay Mandal, Steven Q Wang, Klaus Busam, et al.
Molecular and Cellular Biology
|
September 1, 2010
Inhibition of human peptide deformylase disrupts mitochondrial function
Sindy Escobar-Alvarez, Jeffrey Gardner, Aneesh Sheth, et al.
Page
of 5